Officials are in New Jersey are expanding the focus of their lawsuit against a top manufacturer of a fentanyl-based medication to include the company’s CEO. New Jersey Attorney General Christopher Porrino announced Friday that the state is amending its current consumer fraud and false claims complaint against Insys Therapeutics, an Arizona-based pharmaceutical manufacturer. Porrino is targeting…
